Central blood pressure under angiotensin and calcium channel blockade

Hypertension

Volumn 54, Issue 4, 2009, Pages 704-706

  Safar, Michel E ^a   Protogerou, Athanase ^b   Blacher, Jacques ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; AZELNIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; OLMESARTAN; VALSARTAN;

AGING; ARTERIAL STIFFNESS; AUGMENTATION INDEX; BLOOD PRESSURE; BRACHIAL ARTERY; DIASTOLIC BLOOD PRESSURE; HEMODYNAMICS; HUMAN; HYPERTENSION; MEAN ARTERIAL PRESSURE; NOTE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; RISK ASSESSMENT; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE; VASODILATATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; AZETIDINECARBOXYLIC ACID; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; DIURETICS; DRUG THERAPY, COMBINATION; HEART RATE; HUMANS; HYDROCHLOROTHIAZIDE; IMIDAZOLES; TETRAZOLES; TREATMENT OUTCOME;

EID: 70349666723     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.137406     Document Type: Note

References (11)

1. Avolio A, Van Bortel L, Boutouyrie P, Cockcroft DW, McEniery CM, Protogerou AD, Roman MJ, Safar ME, Segers P, Smulyan H. The role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. Hypertension. 2009;54:375-383
2. Matsui Y, Eguchi K, O'Rourke MF, Ishikawa J, Miyashita H, Shimada K, Kario K. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension. 2009;54: 716-723
3. London GM, Asmar RG, O'Rourke MF, Safar ME; the REASON Project. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol. 2004;43:92-99
4. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) Study. Circulation. 2006;113:1213-1225
5. Lehoux S, Esposito B, Merval R, Tedgui A. Differential regulation of vascular focal adhesion kinase by steady stretch and pulsatility. Circulation. 2005;111:643-649
6. Kakou A, Bézie Y, Mercier N, Louis H, Labat C, Challande P, Lacolley P, Safar ME. Selective reduction of central pulse pressure under angio- tensin blockage in SHR: role of the fibronectin-5-1 integrin complex. Am J Hypertens. 2009;22:711-717
7. Labat C, Lacolley P, Lajemi M, de Gasparo M, Safar ME, Benetos A. Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet. Hypertension. 2001; 38:439-443
8. Agabiti-Rosei E, Heagerty AM, Rizzoni D. Effects of antihypertensive treatment on small artery remodelling. J Hypertens. 2009;27: 1107-1114
9. Safar ME, Blacher J, Protogerou A, Achimastos A. Arterial stiffness and central hemodynamics in treated hypertensive subjects according to brachial blood pressure classification. J Hypertens. 2008;26: 130-137
10. Protogerou A, Blacher J, Stergiou GS, Achimastos A, Safar ME. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) Study. J Am Coll Cardiol. 2009; 53:445-451
11. Blacher J, Evans A, Arveiler D, Amouyel P, Ferrieres J, Bingham A, Yarnell J, Haas B, Montaye M, Ruidavets JB, Ducimetieere P. Residual cardiovascular risk in treated hypertension and hyperlipemia: the PRIME Study. J Hum Hypertens. Epub ahead of print May 28, 2009. DOI: 10.1038/jhh.2009.34